Abstract
LY163892 is a carbacephem antibiotic for oral administration with an antibacterial spectrum similar to that of cefaclor and amoxicillin-clavulanic acid. It has greater stability than cefaclor and greater activity against β-lactamase-producing Haemophilus influenzae and Escherichia coli. LY163892 is less active than amoxicillin against streptococci and less active than amoxicillin-clavulanic acid against Branhamella catarrhalis but comparable against other pathogens.
Original language | English (US) |
---|---|
Pages (from-to) | 268-270 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 32 |
Issue number | 2 |
DOIs | |
State | Published - 1988 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases